Hanmi Pharm. Co., Ltd.

KSE 128940.KS

Hanmi Pharm. Co., Ltd. Total Assets for the year ending December 31, 2023: USD 1.46 B

Hanmi Pharm. Co., Ltd. Total Assets is USD 1.46 B for the year ending December 31, 2023, a -4.09% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Hanmi Pharm. Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 1.52 B, a -6.21% change year over year.
Hanmi Pharm. Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 1.62 B, a -6.17% change year over year.
Hanmi Pharm. Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 1.73 B, a 4.73% change year over year.
Hanmi Pharm. Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 1.65 B, a 9.11% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

KSE: 128940.KS

Hanmi Pharm. Co., Ltd.

CEO	Mr. Jae-Hyun Park
IPO Date	July 30, 2010
Location	South Korea
Headquarters	14, Wiryeseong-daero
Employees	2,270
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.

Key trends

Past 5 years